Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis

Background: Dimethyl fumarate (DMF) is a drug currently in use in oral therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) due to its immunomodulatory and neuroprotective effects. The mechanisms by which DMF exerts its therapeutic effects in MS and in particular its influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerriero, Claudia, Puliatti, Giulia, Di Marino, Tamara, Tata, Ada Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998768/
https://www.ncbi.nlm.nih.gov/pubmed/35408975
http://dx.doi.org/10.3390/ijms23073615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998768/
https://www.ncbi.nlm.nih.gov/pubmed/35408975
http://dx.doi.org/10.3390/ijms23073615

Ejemplares similares